Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Indigotindisulfonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 known ✓ | O43570 | 1/20 | 0.44 |
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.44 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.44 |
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 7/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | CASP9 | P55211 | 1/20 | 0.42 |
| ▸ | PKLR | P30613 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Indigotindisulfonate SCHEMBL3206773 | 1.00 | CA12 (0.44) | CA12CA1CA2CA9CASP3 | |
| Indigotindisulfonate SCHEMBL40486 | 0.92 | CA12 (0.50) | CA12CA1CA2CA9CASP3 | |
| Indigotindisulfonate SCHEMBL118376 | 0.92 | CA12 (0.50) | CA12CA1CA2CA9CASP3 | |
| Indigotindisulfonate SCHEMBL29352151 | 0.92 | CA12 (0.50) | CA12CA1CA2CA9CASP3 | |
| Indigotindisulfonate SCHEMBL186297 | 0.92 | CA12 (0.50) | CA12CA1CA2CA9CASP3 | |
| Indigotindisulfonate SCHEMBL2727226 | 0.92 | CA12 (0.50) | CA12CA1CA2CA9CASP3 | |
| Indigotindisulfonate SCHEMBL5455215 | 0.92 | CA12 (0.50) | CA12CA1CA2CA9CASP3 | |
| Indigotindisulfonate SCHEMBL2732840 | 0.92 | CA12 (0.50) | CA12CA1CA2CA9CASP3 | |
| Indigotindisulfonate SCHEMBL29387846 | 0.92 | CA12 (0.50) | CA12CA1CA2CA9CASP3 | |
| Indigotindisulfonate SCHEMBL3652418 | 0.90 | CA12 (0.49) | CA12CA1CA2CA9CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4750804-B2 | — | — | 2011-08-17 | — | — | JP | claimed |
| US-20080306026-A1 | Capsule Formulation | SYNGENTA CROP PROTECTION LLC | 2008-12-11 | — | — | US | claimed |
| JP-2008531514-A | — | — | 2008-08-14 | — | — | JP | claimed |
| EP-1850664-A2 | PESTICIDAL CAPSULE FORMULATION | Syngeta Participations AG (CH) | 2007-11-07 | — | — | EP | claimed |
| WO-2006089747-A2 | PRESTICIDAL CAPSULE FORMULATION | SYNGENTA PARTICIPATIONS AG (CH) | 2006-08-31 | — | — | WO | claimed |
| US-20030203007-A1 | Pharmaceutical composition reduced in bitter taste and the like | EISAI CO., LTD. | 2003-10-30 | — | — | US | claimed |
| US-6576677-B1 | Including polyvinylpyrrolidone and/or copolymer; suppressing precipitation or decomposition | EISAI CO., LTD. (JP) | 2003-06-10 | — | — | US | claimed |
| US-10259946-B1 | Sealing agents, methods of making and uses thereof | James Hardie Technology Limited (IE) | 2019-04-16 | — | — | US | disclosed |
| US-9204630-B2 | Capsule formulation | SYNGENTA PARTICIPATIONS AG (CH) | 2015-12-08 | — | — | US | disclosed |
| US-20100086603-A1 | COMPOSITION FOR PHOTOPROTECTION | SYNGENTA CROP PROTECTION, INC. (US) | 2010-04-08 | — | — | US | disclosed |
| US-7670391-B2 | Dye-containing pellets for coloring keratin fibers | WELLA AG (DE) | 2010-03-02 | — | — | US | disclosed |
| EP-2068626-A2 | COMPOSITION FOR PHOTOPROTECTION | Syngenta Limited (GB) | 2009-06-17 | — | — | EP | disclosed |
| US-20090056039-A1 | DYE-CONTAINING PELLETS FOR COLORING KERATIN FIBERS | HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) | 2009-03-05 | — | — | US | disclosed |
| US-20040098815-A1 | Coluoring agent for keratin fibres | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2004-05-27 | — | — | US | disclosed |
| US-20030203007-A1 | Pharmaceutical composition reduced in bitter taste and the like | EISAI CO., LTD. | 2003-10-30 | — | — | US | disclosed |
| US-20030159222-A1 | Oxidation dye | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2003-08-28 | — | — | US | disclosed |
| US-6576677-B1 | Including polyvinylpyrrolidone and/or copolymer; suppressing precipitation or decomposition | EISAI CO., LTD. (JP) | 2003-06-10 | — | — | US | disclosed |
| US-20020189031-A1 | Use of salts for improving the absorption qualities of anionic direct dyes | WELLA AKTIENGESELLSCHAFT (DE) | 2002-12-19 | — | — | US | disclosed |
| US-6379400-B1 | DYEING FIBERS, SOLVENT OF WATER OR ALCOHOL AND NITROANILINE DYE | WELLA AKTIENGESELLSCHAFT (DE) | 2002-04-30 | — | — | US | disclosed |
| EP-1025858-A1 | MEDICINAL COMPOSITIONS WITH RELIEVED BITTERNESS, ETC. | Eisai Co., Ltd. (JP) | 2000-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030159222-A1 | Oxidation dye | KRT18, NOX4, VIM | CA12 511/4885CA1 1009/4885CA2 428/4885 |
| US-20040098815-A1 | Coluoring agent for keratin fibres | KRT18, DSG1, KIF5B | CA12 692/4885CA1 1420/4885CA2 3481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.